Don’t miss expert insights into a shift in cancer management.
Join oncology experts and Informa Pharma Intelligence for an enlightening discussion of early cancer detection diagnostics. Rather than focusing on new cancer-fighting modalities and late-stage intervention, they argue that better patient outcomes and cost savings can be realized through the use of early stage detection tools and technology.
Transforming Cancer Treatment With Early Detection Diagnostics: Opportunities and Obstacles
Thursday, October 22, 2020
8am PDT/11 am EDT/4pm BST
Our Panel
 |
Harris Kaplan Managing Partner
Red Team Associates
|
|
|
|
 |
Dr. Azra Raza Professor of Medicine and Director of the MDS Center at Columbia University |
|
|
|
 |
Helmy Eltoukhy, PHD
Chief Executive Officer Guardant Health
|
|
|
 |
Sam Asgarian M.D.
Chief Medical Officer
Thrive Earlier Detection
|
|
 |
Phil Greenfield Editor-In-Chief
Pharma Intelligence
|
|
|
